Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (591) 591
science & technology (442) 442
life sciences & biomedicine (429) 429
leukemia, myelogenous, chronic, bcr-abl positive - physiopathology (372) 372
hematology (228) 228
male (212) 212
female (201) 201
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (198) 198
biological and medical sciences (185) 185
adult (181) 181
oncology (181) 181
medical sciences (174) 174
middle aged (173) 173
leukemia (121) 121
leukemia, myelogenous, chronic, bcr-abl positive - genetics (119) 119
chronic myeloid leukemia (117) 117
hematologic and hematopoietic diseases (114) 114
imatinib mesylate (112) 112
antineoplastic agents - therapeutic use (108) 108
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (106) 106
aged (105) 105
leukemia, myelogenous, chronic, bcr-abl positive - pathology (105) 105
animals (103) 103
leukemia, myelogenous, chronic, bcr-abl positive - therapy (102) 102
benzamides (97) 97
pyrimidines - therapeutic use (84) 84
piperazines - therapeutic use (76) 76
abridged index medicus (73) 73
cancer (56) 56
adolescent (55) 55
protein kinase inhibitors - therapeutic use (55) 55
leukemia, myelogenous, chronic, bcr-abl positive - complications (54) 54
fusion proteins, bcr-abl - genetics (52) 52
cell biology (51) 51
mice (50) 50
bone marrow transplantation (48) 48
prognosis (48) 48
antineoplastic agents - adverse effects (45) 45
research (45) 45
hemic and lymphatic diseases (44) 44
medicine & public health (44) 44
stem cells (44) 44
transplantation (44) 44
care and treatment (43) 43
antineoplastic agents (41) 41
immunology (40) 40
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (40) 40
pyrimidines - adverse effects (40) 40
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (39) 39
fusion proteins, bcr-abl - metabolism (38) 38
imatinib (38) 38
philadelphia chromosome (38) 38
signal transduction (38) 38
apoptosis (37) 37
pharmacology. drug treatments (37) 37
transplantation, homologous (37) 37
medicine, research & experimental (36) 36
research & experimental medicine (36) 36
aged, 80 and over (35) 35
cml (34) 34
protein kinase inhibitors - adverse effects (34) 34
analysis (33) 33
biochemistry & molecular biology (33) 33
child (33) 33
treatment outcome (33) 33
antineoplastic agents - pharmacology (32) 32
disease progression (32) 32
precursor cell lymphoblastic leukemia-lymphoma - physiopathology (32) 32
risk factors (32) 32
genetic aspects (31) 31
hematopoiesis (31) 31
leukemia, myelogenous, chronic, bcr-abl positive - blood (31) 31
piperazines - adverse effects (31) 31
general & internal medicine (30) 30
hematopoietic stem cell transplantation (29) 29
medicine, general & internal (29) 29
protein-tyrosine kinases - antagonists & inhibitors (29) 29
bcr-abl (28) 28
leukemia - physiopathology (28) 28
time factors (28) 28
bone marrow (27) 27
chemotherapy (27) 27
drug resistance, neoplasm (27) 27
pyrimidines - pharmacology (27) 27
bone marrow - pathology (26) 26
follow-up studies (26) 26
hematopoietic stem cells (26) 26
interferon-alpha - therapeutic use (26) 26
k562 cells (26) 26
hematopoietic stem cells - physiology (25) 25
mutation (25) 25
pharmacology & pharmacy (25) 25
piperazines - pharmacology (25) 25
proteins (25) 25
gene expression (24) 24
tyrosine (24) 24
apoptosis - drug effects (23) 23
chronic myelogenous leukemia (23) 23
health aspects (23) 23
pyrimidines - administration & dosage (23) 23
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (581) 581
Japanese (13) 13
French (12) 12
Chinese (6) 6
Russian (6) 6
Polish (5) 5
Spanish (4) 4
German (3) 3
Dutch (2) 2
Czech (1) 1
Hebrew (1) 1
Hungarian (1) 1
Italian (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia
by Ren, Ruibao
Nature reviews. Cancer, ISSN 1474-175X, 03/2005, Volume 5, Issue 3, pp. 172 - 183
Life Sciences & Biomedicine | Oncology | Science & Technology | Oncogene Proteins v-abl - pharmacology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - physiopathology | Humans | Gene Expression Regulation, Neoplastic | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Pyrimidines - pharmacology | Imatinib Mesylate | Piperazines - pharmacology | Proto-Oncogene Proteins c-abl - pharmacology | Animals | Cell Transformation, Neoplastic | Genes, abl | Antineoplastic Agents - pharmacology | Mice | Benzamides | Disease Models, Animal | Care and treatment | Translocation (Genetics) | Physiological aspects | Genetic aspects | Chronic myeloid leukemia | Research | Hematopoietic stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text A review of the European LeukemiaNet recommendations for the management of CML
by Baccarani, Michele and Castagnetti, Fausto and Gugliotta, Gabriele and Rosti, Gianantonio
Annals of hematology, ISSN 0939-5555, 04/2015, Volume 94, Issue 2, pp. 141 - 147
Chronic myeloid leukemia | Tyrosine kinase inhibitors | BCR-ABL1 | Philadelphia chromosome | Life Sciences & Biomedicine | Hematology | Science & Technology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - physiopathology | Drug Resistance, Multiple | Voluntary Health Agencies | Europe | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Evidence-Based Medicine | Disease Progression | Fusion Proteins, bcr-abl - genetics | Antineoplastic Agents - adverse effects | Protein Kinase Inhibitors - therapeutic use | Fusion Proteins, bcr-abl - antagonists & inhibitors | Mutation | Drug Monitoring | Fusion Proteins, bcr-abl - metabolism | Practice Guidelines as Topic | Analysis | Leukemia | Stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia
by Schiffer, Charles A
The New England journal of medicine, ISSN 0028-4793, 07/2007, Volume 357, Issue 3, pp. 258 - 265
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Chromosome aberrations | Medical genetics | Dasatinib | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - physiopathology | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Piperazines - therapeutic use | Protein Kinase Inhibitors - adverse effects | Thiazoles - therapeutic use | Imatinib Mesylate | Piperazines - adverse effects | Fusion Proteins, bcr-abl | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Adult | Female | Benzamides | Practice Guidelines as Topic | Protein-Tyrosine Kinases - antagonists & inhibitors | Case studies | Transplantation | Chronic myeloid leukemia | Health aspects | Stem cells | Bone marrow | Chromosomes | Leukemia | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Molecular biology of bcr-abl1-positive chronic myeloid leukemia
by Quintás-Cardama, Alfonso and Cortes, Jorge
Blood, ISSN 0006-4971, 02/2009, Volume 113, Issue 8, pp. 1619 - 1630
Life Sciences & Biomedicine | Hematology | Science & Technology | Fusion Proteins, bcr-abl - genetics | Animals | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - physiopathology | Molecular Biology | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Signal Transduction - physiology | Fusion Proteins, bcr-abl - metabolism | Gene Expression Regulation, Leukemic - physiology | Index Medicus | Abridged Index Medicus | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Bcr-Abl-mediated redox regulation of the PI3K AKT pathway
by Naughton, R and Quiney, C and Turner, S.D and Cotter, T.G
Leukemia, ISSN 0887-6924, 08/2009, Volume 23, Issue 8, pp. 1432 - 1440
Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Reactive Oxygen Species - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - physiopathology | Oxidation-Reduction | Humans | NADPH Oxidases - antagonists & inhibitors | Neoplasm Proteins - physiology | RNA, Small Interfering - pharmacology | Glycogen Synthase Kinase 3 beta | Proto-Oncogene Proteins c-akt - physiology | NADPH Oxidase 4 | Onium Compounds - pharmacology | Glycogen Synthase Kinase 3 - metabolism | beta Catenin - metabolism | Hydrogen Peroxide - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Protein Phosphatase 1 - antagonists & inhibitors | Fusion Proteins, bcr-abl - physiology | Myeloid Cell Leukemia Sequence 1 Protein | NADPH Oxidases - genetics | Phosphatidylinositol 3-Kinases - physiology | Signal Transduction - physiology | Apoptosis - physiology | Cell Line, Tumor - metabolism | NADPH Oxidases - physiology | Cell proliferation | Cell lines | Physiological aspects | Genetic aspects | Chronic myeloid leukemia | Research | Gene expression | Apoptosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Natural course and biology of CML
by Chereda, Bradley and Melo, Junia V
Annals of hematology, ISSN 0939-5555, 04/2015, Volume 94, Issue 2, pp. 107 - 121
Signal transduction | Chronic myeloid leukaemia | Tyrosine kinase inhibitors | BCR-ABL | Philadelphia chromosome | Life Sciences & Biomedicine | Hematology | Science & Technology | Animals | Prognosis | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - physiopathology | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Neoplasm Proteins - chemistry | Mutation | Neoplasm Proteins - genetics | Neoplasm Proteins - metabolism | Disease Progression | Leukemia | Cellular signal transduction | Stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights